Telo Genomics Corp Stock Probability of Future Stock Price Finishing Under 0
| TELO Stock | CAD 0.12 0.01 7.69% |
Telo |
Telo Genomics Target Price Odds to finish below 0
The tendency of Telo Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to C$ 0.00 or more in 90 days |
| 0.12 | 90 days | 0.00 | near 1 |
Based on a normal probability distribution, the odds of Telo Genomics to drop to C$ 0.00 or more in 90 days from now is near 1 (This Telo Genomics Corp probability density function shows the probability of Telo Stock to fall within a particular range of prices over 90 days) . Probability of Telo Genomics Corp price to stay between C$ 0.00 and its current price of C$0.12 at the end of the 90-day period is about 13.23 .
Assuming the 90 days trading horizon Telo Genomics Corp has a beta of -0.89. This usually implies Additionally Telo Genomics Corp has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Telo Genomics Price Density |
| Price |
Predictive Modules for Telo Genomics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Telo Genomics Corp. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Telo Genomics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Telo Genomics is not an exception. The market had few large corrections towards the Telo Genomics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Telo Genomics Corp, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Telo Genomics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.57 | |
β | Beta against Dow Jones | -0.89 | |
σ | Overall volatility | 0.03 | |
Ir | Information ratio | -0.13 |
Telo Genomics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Telo Genomics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Telo Genomics Corp can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Telo Genomics Corp generated a negative expected return over the last 90 days | |
| Telo Genomics Corp has high historical volatility and very poor performance | |
| Telo Genomics Corp has some characteristics of a very speculative penny stock | |
| Telo Genomics Corp has high likelihood to experience some financial distress in the next 2 years | |
| Telo Genomics Corp has accumulated 32.5 K in total debt. Telo Genomics Corp has a current ratio of 0.09, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Telo Genomics until it has trouble settling it off, either with new capital or with free cash flow. So, Telo Genomics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Telo Genomics Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Telo to invest in growth at high rates of return. When we think about Telo Genomics' use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (2.82 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Telo Genomics Corp has accumulated about 24.25 K in cash with (2.63 M) of positive cash flow from operations. | |
| Latest headline from news.google.com: Nubeva Technologies Degree of Operating Leverage 2.13 - GuruFocus.com |
Telo Genomics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Telo Stock often depends not only on the future outlook of the current and potential Telo Genomics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Telo Genomics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 60.2 M | |
| Cash And Short Term Investments | 2.7 M |
Telo Genomics Technical Analysis
Telo Genomics' future price can be derived by breaking down and analyzing its technical indicators over time. Telo Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Telo Genomics Corp. In general, you should focus on analyzing Telo Stock price patterns and their correlations with different microeconomic environments and drivers.
Telo Genomics Predictive Forecast Models
Telo Genomics' time-series forecasting models is one of many Telo Genomics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Telo Genomics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Telo Genomics Corp
Checking the ongoing alerts about Telo Genomics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Telo Genomics Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Telo Genomics Corp generated a negative expected return over the last 90 days | |
| Telo Genomics Corp has high historical volatility and very poor performance | |
| Telo Genomics Corp has some characteristics of a very speculative penny stock | |
| Telo Genomics Corp has high likelihood to experience some financial distress in the next 2 years | |
| Telo Genomics Corp has accumulated 32.5 K in total debt. Telo Genomics Corp has a current ratio of 0.09, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Telo Genomics until it has trouble settling it off, either with new capital or with free cash flow. So, Telo Genomics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Telo Genomics Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Telo to invest in growth at high rates of return. When we think about Telo Genomics' use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (2.82 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Telo Genomics Corp has accumulated about 24.25 K in cash with (2.63 M) of positive cash flow from operations. | |
| Latest headline from news.google.com: Nubeva Technologies Degree of Operating Leverage 2.13 - GuruFocus.com |
Additional Tools for Telo Stock Analysis
When running Telo Genomics' price analysis, check to measure Telo Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telo Genomics is operating at the current time. Most of Telo Genomics' value examination focuses on studying past and present price action to predict the probability of Telo Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telo Genomics' price. Additionally, you may evaluate how the addition of Telo Genomics to your portfolios can decrease your overall portfolio volatility.